Literature DB >> 7137171

Malignant pericardial mesotheliomas and asbestos exposure: a case report.

B Beck, G Konetzke, V Ludwig, W Röthig, W Sturm.   

Abstract

Three cases of malignant pericardial mesotheliomas are presented with evidence of occupational asbestos exposure. Examination results are compared with findings from experimental and epidemiological research on biological effects of asbestos dust. There are sufficient indications that time-limited effects of asbestos dust established either by measurements or assessment of the amount of concentration after a latency of more than 20 years are apt to result in the development of mesotheliomas of the pleura and peritoneum and, moreover, the pericardium. It is suggested that malignant pericardial mesothelioma also be recognized as another form of occupational disease caused by asbestos dust.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137171     DOI: 10.1002/ajim.4700030205

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  5 in total

1.  Asbestos induced pericardial effusion and constrictive pericarditis.

Authors:  D Davies; M I Andrews; J S Jones
Journal:  Thorax       Date:  1991-06       Impact factor: 9.139

Review 2.  Primary malignant mesothelioma of the pericardium. Case report and literature review.

Authors:  R Thomason; W Schlegel; M Lucca; S Cummings; S Lee
Journal:  Tex Heart Inst J       Date:  1994

3.  Desmoplastic malignant mesothelioma of the pericardium: Description of a case and review of the literature.

Authors:  Antonello Nicolini; Alessandro Perazzo; Sergio Lanata
Journal:  Lung India       Date:  2011-07

4.  Grand rounds: asbestos-related pericarditis in a boiler operator.

Authors:  Belayneh A Abejie; Eugene H Chung; Richard W Nesto; Stefanos N Kales
Journal:  Environ Health Perspect       Date:  2008-01       Impact factor: 9.031

5.  Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?

Authors:  Brent D Kerger; Robert C James; David A Galbraith
Journal:  Front Genet       Date:  2014-05-30       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.